Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 2573-2578, July 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newberne, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newberne, P. M.

Experimental Hepatocellular Carcinogenesis1

Paul M. Newberne

Department of Nutrition and Food Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

The sequential development of lesions in the liver leading to hepatocellular carcinoma in experimental animals appears to follow a similar pattern irrespective of the carcinogen. The speed with which the lesions develop is related to the chemical, the dose and dosing schedule, and the diet fed. In studies with aflatoxin B1 there is a predictable series of morphological expressions beginning with focal areas of hydropic degeneration (Stage 1); hyperplastic basophilic cells, singly or in close association with Stage 1 (Stage 2); nodular hyperplasia of parenchymal cells which become progressively more abnormal (Stage 3); transitional cell changes (Stage 4); and, ultimately, hepatocellular carcinoma (Stage 5).

In our judgment, Stages 1, 2, and 3 may be necessary but not sufficient alterations to result in cancer. Cells in Stages 2 and 3 may have undergone reversible transformations and may never progress to malignancy. The cells in Stages 1 and 2 exhibit early a loss of several enzymes identified histochemically, but the extent of the loss appears to vary according to the time in development at which the lesion is sampled. Labeling with [3H]thymidine indicates an early burst of DNA synthesis in the small basophilic foci, followed by expansion of the area with labeling of cells at the periphery and few if any in the center. Later, in Stage 3, cells at the center of the lesion again label, and, in Stage 4, labeled cells and mitoses are abundant. Stage 3 may or may not be reversible, but not all such lesions progress to carcinoma. Stage 4 probably is irreversible; the cells and architecture are markedly abnormal and may be considered premalignant. Correlation of the marker enzyme deficiency, cell turnover indices, biochemical alterations, and morphological changes can aid in elucidation of cellular evolution culminating in neoplasia. Manipulation of dietary treatment offers a powerful tool in these studies.

1 Presented at the Conference "Early Lesions and the Development of Epithelial Cancer," October 21 to 23, 1975, Bethesda, Md.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.